Joel Greenblatt Ionis Pharmaceuticals Inc Transaction History

Gotham Asset Management, LLC

$10.2 Billion
Q4 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 6,260 shares of IONS stock, worth $177,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,260

Previous 6,262 0.03%

Holding current value

$177,784

Previous $250,000 12.8%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$33.73 - $40.36 $67 - $80	-2 Reduced 0.03%	6,260 $218,000
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $19,099 - $24,994	-524 Reduced 7.72%	6,262 $298,000
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $8,532 - $10,870	-203 Reduced 2.9%	6,786 $294,000
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $47,685 - $56,741	-1,099 Reduced 13.59%	6,989 $353,000
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $885 - $1,083	23 Added 0.29%	8,088 $366,000
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $179,484 - $223,929	-5,168 Reduced 39.05%	8,065 $330,000
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $1.9 Million - $2.33 Million	-56,663 Reduced 81.07%	13,233 $472,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $1.73 Million - $2.17 Million	46,656 Added 200.76%	69,896 $2.64 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $1.4 Million - $1.86 Million	-38,244 Reduced 62.2%	23,240 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $731,137 - $991,451	23,057 Added 60.0%	61,484 $2.28 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $1.15 Million - $1.42 Million	38,427 New	38,427 $1.42 Million
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $4.59 Million - $5.98 Million	-97,992 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $1.82 Million - $2.77 Million	43,645 Added 80.31%	97,992 $4.63 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $7.99 Million - $9.69 Million	-148,409 Reduced 73.2%	54,347 $3.28 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $3.4 Million - $4.15 Million	57,566 Added 39.65%	202,756 $12.2 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $8.31 Million - $11.5 Million	133,840 Added 1179.21%	145,190 $9.33 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $600,642 - $921,279	11,350 New	11,350 $921,000
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $1.31 Million - $1.64 Million	-32,409 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $3.56 Million - $4.44 Million	-80,668 Reduced 71.34%	32,409 $1.43 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $8.88 Million - $11.4 Million	-176,531 Reduced 60.96%	113,077 $5.69 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $13.2 Million - $17.3 Million	289,608	289,608 $14.7 Million

Others Institutions Holding IONS

# of Institutions

408

Shares Held

131M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.03B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account